These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 25701017)

  • 1. European Primary Care Cardiovascular Society (EPCCS) consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care.
    Hobbs FR; Taylor CJ; Jan Geersing G; Rutten FH; Brouwer JR;
    Eur J Prev Cardiol; 2016 Mar; 23(5):460-73. PubMed ID: 25701017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation anticoagulation care in a large urban family medicine practice.
    Valentinis A; Ivers N; Bhatia S; Meshkat N; Leblanc K; Ha A; Morra D
    Can Fam Physician; 2014 Mar; 60(3):e173-9. PubMed ID: 24627401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis.
    Lip GY; Andreotti F; Fauchier L; Huber K; Hylek E; Knight E; Lane DA; Levi M; Marin F; Palareti G; Kirchhof P; ; Collet JP; Rubboli A; Poli D; Camm J
    Europace; 2011 May; 13(5):723-46. PubMed ID: 21515596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub-Analysis From the PREFER in AF (
    Patti G; Lucerna M; Pecen L; Siller-Matula JM; Cavallari I; Kirchhof P; De Caterina R
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28736385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: barriers to and strategies for optimal implementation.
    Camm AJ; Pinto FJ; Hankey GJ; Andreotti F; Hobbs FD;
    Europace; 2015 Jul; 17(7):1007-17. PubMed ID: 26116685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Patients With Atrial Fibrillation Newly Recommended for Oral Anticoagulation Under the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline.
    Gray MP; Saba S; Zhang Y; Hernandez I
    J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29301756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation.
    Mason PK; Lake DE; DiMarco JP; Ferguson JD; Mangrum JM; Bilchick K; Moorman LP; Moorman JR
    Am J Med; 2012 Jun; 125(6):603.e1-6. PubMed ID: 22502952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. North American Thrombosis Forum, AF Action Initiative Consensus Document.
    Ruff CT; Ansell JE; Becker RC; Benjamin EJ; Deicicchi DJ; Mark Estes NA; Ezekowitz MD; Fanikos J; Fareed J; Garcia D; Giugliano RP; Goldhaber SZ; Granger C; Healey JS; Hull R; Hylek EM; Libby P; Lopes RD; Mahaffey KW; Mega J; Piazza G; Sasahara AA; Sorond FA; Spyropoulos AC; Walenga JM; Weitz JI
    Am J Med; 2016 May; 129(5 Suppl):S1-S29. PubMed ID: 27126598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ESC guidelines on atrial fibrillation 2016 : Summary of the most relevant recommendations and modifications].
    Eckardt L; Häusler KG; Ravens U; Borggrefe M; Kirchhof P
    Herz; 2016 Dec; 41(8):677-683. PubMed ID: 27847992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expert consensus of the French society of geriatrics and gerontology and the French society of cardiology on the management of atrial fibrillation in elderly people].
    Hanon O; Assayag P; Belmin J; Collet JP; Emeriau JP; Fauchier L; Forette F; Friocourt P; Gentric A; Leclercq C; Komajda M; Le Heuzey JY;
    Geriatr Psychol Neuropsychiatr Vieil; 2013 Jun; 11(2):117-43. PubMed ID: 23803629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk.
    Potpara TS; Lip GY
    Prog Cardiovasc Dis; 2015; 58(2):177-94. PubMed ID: 26162958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
    BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.
    van Nieuwenhuizen KM; van der Worp HB; Algra A; Kappelle LJ; Rinkel GJ; van Gelder IC; Schutgens RE; Klijn CJ;
    Trials; 2015 Sep; 16():393. PubMed ID: 26340977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA).
    Lip GYH; Collet JP; Haude M; Byrne R; Chung EH; Fauchier L; Halvorsen S; Lau D; Lopez-Cabanillas N; Lettino M; Marin F; Obel I; Rubboli A; Storey RF; Valgimigli M; Huber K;
    Europace; 2019 Feb; 21(2):192-193. PubMed ID: 30052888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.
    Gage BF; van Walraven C; Pearce L; Hart RG; Koudstaal PJ; Boode BS; Petersen P
    Circulation; 2004 Oct; 110(16):2287-92. PubMed ID: 15477396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital Discharge.
    Dupree L; DeLosSantos M; Smotherman C
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):502-508. PubMed ID: 29806486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
    Ramlawi B; Abu Saleh WK; Edgerton J
    Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.